Related Experiment Video
Updated: Aug 23, 2025

08:30
Operant Procedures for Assessing Behavioral Flexibility in Rats
Published on: February 15, 2015
21.0K
Sustained MK-801 induced deficit in a novel probabilistic reversal learning task
Patrick Latuske1, Moritz von Heimendahl1, Serena Deiana1
1Central Nervous System Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany.
Frontiers in Pharmacology
|October 31, 2022
Summary
A new time-based probabilistic reversal learning (PRL) task in rats shows improved sensitivity to cognitive flexibility deficits. This enhanced method aids in preclinical drug development for neuropsychiatric disorders.
Area of Science:
- Neuroscience
- Behavioral Pharmacology
Background:
- Cognitive flexibility is crucial for daily functioning but often impaired in neuropsychiatric diseases.
- Current rodent models struggle to quantitatively assess cognitive flexibility deficits, limiting drug development.
Purpose of the Study:
- To develop a novel, more sensitive rat probabilistic reversal learning (PRL) task for assessing cognitive flexibility.
- To compare the efficacy of a time-based PRL task against a performance-based PRL task in detecting drug-induced deficits.
Main Methods:
- Developed a novel time-based PRL task in rats with extended intervals between contingency reversals.
- Administered MK-801, an NMDA receptor antagonist, to assess its effects on cognitive flexibility in both time-based and performance-based PRL tasks.
- Quantitatively compared behavioral performance and reinforcement learning model parameters between the two PRL task variants.
Main Results:
- The time-based PRL task demonstrated increased sensitivity to MK-801, inducing sustained reversal learning deficits.
- The performance-based PRL task showed only transient, weak effects at the same MK-801 dose.
- Time-based PRL provided more robust estimates of behavioral and reinforcement learning parameters.
Conclusions:
- The novel time-based PRL task offers a more sensitive and quantitative method for evaluating cognitive flexibility in preclinical models.
- This enhanced PRL paradigm facilitates the efficient testing and development of novel therapeutic agents for cognitive impairments in neuropsychiatric disorders.

